SARS-CoV-2 : fear versus data
Copyright © 2020 Elsevier Ltd. All rights reserved..
SARS-CoV-2, the novel coronavirus from China, is spreading around the world, causing a huge reaction despite its current low incidence outside China and the Far East. Four common coronaviruses are in current circulation and cause millions of cases worldwide. This article compares the incidence and mortality rates of these four common coronaviruses with those of SARS-CoV-2 in Organisation for Economic Co-operation and Development countries. It is concluded that the problem of SARS-CoV-2 is probably being overestimated, as 2.6 million people die of respiratory infections each year compared with less than 4000 deaths for SARS-CoV-2 at the time of writing.
| Errataetall: |
CommentIn: Int J Antimicrob Agents. 2020 Oct;56(4):106074. - PMID 32629113 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:55 |
|---|---|
| Enthalten in: |
International journal of antimicrobial agents - 55(2020), 5 vom: 15. Mai, Seite 105947 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Roussel, Yanis [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 28.05.2020 Date Revised 10.01.2021 published: Print-Electronic CommentIn: Int J Antimicrob Agents. 2020 Oct;56(4):106074. - PMID 32629113 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ijantimicag.2020.105947 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM307876586 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM307876586 | ||
| 003 | DE-627 | ||
| 005 | 20231225130528.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ijantimicag.2020.105947 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1026.xml |
| 035 | |a (DE-627)NLM307876586 | ||
| 035 | |a (NLM)32201354 | ||
| 035 | |a (PII)S0924-8579(20)30097-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Roussel, Yanis |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a SARS-CoV-2 |b fear versus data |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.05.2020 | ||
| 500 | |a Date Revised 10.01.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: Int J Antimicrob Agents. 2020 Oct;56(4):106074. - PMID 32629113 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2020 Elsevier Ltd. All rights reserved. | ||
| 520 | |a SARS-CoV-2, the novel coronavirus from China, is spreading around the world, causing a huge reaction despite its current low incidence outside China and the Far East. Four common coronaviruses are in current circulation and cause millions of cases worldwide. This article compares the incidence and mortality rates of these four common coronaviruses with those of SARS-CoV-2 in Organisation for Economic Co-operation and Development countries. It is concluded that the problem of SARS-CoV-2 is probably being overestimated, as 2.6 million people die of respiratory infections each year compared with less than 4000 deaths for SARS-CoV-2 at the time of writing | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Coronavirus | |
| 650 | 4 | |a SARS-CoV-2 | |
| 700 | 1 | |a Giraud-Gatineau, Audrey |e verfasserin |4 aut | |
| 700 | 1 | |a Jimeno, Marie-Thérèse |e verfasserin |4 aut | |
| 700 | 1 | |a Rolain, Jean-Marc |e verfasserin |4 aut | |
| 700 | 1 | |a Zandotti, Christine |e verfasserin |4 aut | |
| 700 | 1 | |a Colson, Philippe |e verfasserin |4 aut | |
| 700 | 1 | |a Raoult, Didier |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of antimicrobial agents |d 1991 |g 55(2020), 5 vom: 15. Mai, Seite 105947 |w (DE-627)NLM090678974 |x 1872-7913 |7 nnns |
| 773 | 1 | 8 | |g volume:55 |g year:2020 |g number:5 |g day:15 |g month:05 |g pages:105947 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ijantimicag.2020.105947 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 55 |j 2020 |e 5 |b 15 |c 05 |h 105947 | ||